283 related articles for article (PubMed ID: 31277274)
1. Role of NS1 and TLR3 in Pathogenesis and Immunity of WNV.
Patel S; Sinigaglia A; Barzon L; Fassan M; Sparber F; LeibundGut-Landmann S; Ackermann M
Viruses; 2019 Jul; 11(7):. PubMed ID: 31277274
[TBL] [Abstract][Full Text] [Related]
2. Replication-Defective West Nile Virus with NS1 Deletion as a New Vaccine Platform for Flavivirus.
Li N; Zhang YN; Deng CL; Shi PY; Yuan ZM; Zhang B
J Virol; 2019 Sep; 93(17):. PubMed ID: 31189715
[TBL] [Abstract][Full Text] [Related]
3. Levels of Circulating NS1 Impact West Nile Virus Spread to the Brain.
Wessel AW; Dowd KA; Biering SB; Zhang P; Edeling MA; Nelson CA; Funk KE; DeMaso CR; Klein RS; Smith JL; Cao TM; Kuhn RJ; Fremont DH; Harris E; Pierson TC; Diamond MS
J Virol; 2021 Sep; 95(20):e0084421. PubMed ID: 34346770
[TBL] [Abstract][Full Text] [Related]
4. Human Monoclonal Antibodies against NS1 Protein Protect against Lethal West Nile Virus Infection.
Wessel AW; Doyle MP; Engdahl TB; Rodriguez J; Crowe JE; Diamond MS
mBio; 2021 Oct; 12(5):e0244021. PubMed ID: 34634945
[TBL] [Abstract][Full Text] [Related]
5. Antibodies generated by immunization with the NS1 protein of West Nile virus confer partial protection against lethal Japanese encephalitis virus challenge.
Sun E; Zhao J; TaoYang ; Xu Q; Qin Y; Wang W; Wei P; Wu D
Vet Microbiol; 2013 Sep; 166(1-2):145-53. PubMed ID: 23834965
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive mapping of West Nile virus (WNV)- and Japanese encephalitis virus serocomplex-specific linear B-cell epitopes from WNV non-structural protein 1.
Sun EC; Zhao J; Liu NH; Yang T; Ma JN; Geng HW; Wang LF; Qin YL; Bu ZG; Yang YH; Lunt RA; Wang LF; Wu DL
J Gen Virol; 2012 Jan; 93(Pt 1):50-60. PubMed ID: 21940411
[TBL] [Abstract][Full Text] [Related]
7. Antibodies against West Nile Virus nonstructural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and -independent mechanisms.
Chung KM; Nybakken GE; Thompson BS; Engle MJ; Marri A; Fremont DH; Diamond MS
J Virol; 2006 Feb; 80(3):1340-51. PubMed ID: 16415011
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and protective efficacy of recombinant Modified Vaccinia virus Ankara candidate vaccines delivering West Nile virus envelope antigens.
Volz A; Lim S; Kaserer M; Lülf A; Marr L; Jany S; Deeg CA; Pijlman GP; Koraka P; Osterhaus AD; Martina BE; Sutter G
Vaccine; 2016 Apr; 34(16):1915-26. PubMed ID: 26939903
[TBL] [Abstract][Full Text] [Related]
9. Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection.
Chu JH; Chiang CC; Ng ML
J Immunol; 2007 Mar; 178(5):2699-705. PubMed ID: 17312111
[TBL] [Abstract][Full Text] [Related]
10. Absence of protection from West Nile virus disease and adverse effects in red legged partridges after non-structural NS1 protein administration.
Rebollo B; Llorente F; Pérez-Ramírez E; Sarraseca J; Gallardo C; Risalde MÁ; Höfle U; Figuerola J; Soriguer RC; Venteo Á; Jiménez-Clavero MÁ
Comp Immunol Microbiol Infect Dis; 2018 Feb; 56():30-33. PubMed ID: 29406280
[TBL] [Abstract][Full Text] [Related]
11. Abrogation of TLR3 inhibition by discrete amino acid changes in the C-terminal half of the West Nile virus NS1 protein.
Morrison CR; Scholle F
Virology; 2014 May; 456-457():96-107. PubMed ID: 24889229
[TBL] [Abstract][Full Text] [Related]
12. Chimeric vaccine composed of viral peptide and mammalian heat-shock protein 60 peptide protects against West Nile virus challenge.
Gershoni-Yahalom O; Landes S; Kleiman-Shoval S; Ben-Nathan D; Kam M; Lachmi BE; Khinich Y; Simanov M; Samina I; Eitan A; Cohen IR; Rager-Zisman B; Porgador A
Immunology; 2010 Aug; 130(4):527-35. PubMed ID: 20331473
[TBL] [Abstract][Full Text] [Related]
13. West Nile Virus NS1 Antagonizes Interferon Beta Production by Targeting RIG-I and MDA5.
Zhang HL; Ye HQ; Liu SQ; Deng CL; Li XD; Shi PY; Zhang B
J Virol; 2017 Sep; 91(18):. PubMed ID: 28659477
[TBL] [Abstract][Full Text] [Related]
14. Modulation of innate immune signaling by the secreted form of the West Nile virus NS1 glycoprotein.
Crook KR; Miller-Kittrell M; Morrison CR; Scholle F
Virology; 2014 Jun; 458-459():172-82. PubMed ID: 24928049
[TBL] [Abstract][Full Text] [Related]
15. TLR3- and MyD88-dependent signaling differentially influences the development of West Nile virus-specific B cell responses in mice following immunization with RepliVAX WN, a single-cycle flavivirus vaccine candidate.
Xia J; Winkelmann ER; Gorder SR; Mason PW; Milligan GN
J Virol; 2013 Nov; 87(22):12090-101. PubMed ID: 23986602
[TBL] [Abstract][Full Text] [Related]
16. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q
Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880
[TBL] [Abstract][Full Text] [Related]
17. Dynamics of Tissue-Specific CD8
Aguilar-Valenzuela R; Netland J; Seo YJ; Bevan MJ; Grakoui A; Suthar MS
J Virol; 2018 May; 92(10):. PubMed ID: 29514902
[TBL] [Abstract][Full Text] [Related]
18. Complex adenovirus-mediated expression of West Nile virus C, PreM, E, and NS1 proteins induces both humoral and cellular immune responses.
Schepp-Berglind J; Luo M; Wang D; Wicker JA; Raja NU; Hoel BD; Holman DH; Barrett AD; Dong JY
Clin Vaccine Immunol; 2007 Sep; 14(9):1117-26. PubMed ID: 17634508
[TBL] [Abstract][Full Text] [Related]
19. Identification of two linear B-cell epitopes from West Nile virus NS1 by screening a phage-displayed random peptide library.
Sun EC; Ma JN; Liu NH; Yang T; Zhao J; Geng HW; Wang LF; Qin YL; Bu ZG; Yang YH; Lunt RA; Wang LF; Wu DL
BMC Microbiol; 2011 Jul; 11():160. PubMed ID: 21729328
[TBL] [Abstract][Full Text] [Related]
20. Vaccination of mice using the West Nile virus E-protein in a DNA prime-protein boost strategy stimulates cell-mediated immunity and protects mice against a lethal challenge.
De Filette M; Soehle S; Ulbert S; Richner J; Diamond MS; Sinigaglia A; Barzon L; Roels S; Lisziewicz J; Lorincz O; Sanders NN
PLoS One; 2014; 9(2):e87837. PubMed ID: 24503579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
